JVI Accepted Manuscript Posted Online 29 March 2017 J. Virol. doi:10.1128/JVI.00260-17 Copyright © 2017 American Society for Microbiology. All Rights Reserved.
The minute virus of canines (MVC) NP1 protein
2
governs the expression of a subset of essential NS proteins
3
via its role in RNA processing
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Olufemi O. Fasina, Stephanie Stupps, Wanda Figueroa-Cuilan, and David J. Pintel* Department of Molecular Microbiology and Immunology University of Missouri-Columbia, School of Medicine Bond Life Sciences Center, Columbia MO USA 65211
Running: MVC NP1 governs viral NS-gene expression
*Corresponding Author: 471f Bond Life Sciences Center 1201 Rollins Rd. Columbia, MO 65211
[email protected] 573-882-3920
1
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
1
32 33
ABSTRACT Parvoviruses use a variety of means to control the expression of their compact genomes. The Bocaparvovirus Minute Virus of Canines (MVC) encodes a small, genus-specific
35
protein, NP1, which governs access to the viral capsid gene via its role in alternative
36
polyadenylation and alternative splicing of the single MVC pre-mRNA. In addition to NP1, MVC
37
encodes five additional non-structural proteins (NS) that share an initiation codon at the left end
38
of the genome and which are individually encoded by alternative multiply-spliced mRNAs. We
39
found that three of these proteins were encoded by mRNAs that excise the NP1-regulated MVC
40
intron immediately upstream of the internal polyadenylation site (pA)p, and that generation of
41
these proteins was thus regulated by NP1. Splicing of their progenitor mRNAs joined the amino
42
terminus of these proteins into the NP1 open reading frame, and splice-site mutations that
43
prevented their expression inhibited virus replication in a host-cell dependent manner. Thus, in
44
addition to controlling capsid gene access, NP1 also controls expression of three of the five
45
identified NS proteins via its role in governing MVC pre-mRNA splicing.
46
IMPORTANCE
47
The Parvovirinae are small non-enveloped icosahedral viruses that are important
48
pathogens in many animal species including humans. Minute virus of canine (MVC) is an
49
autonomous parvovirus in the Bocaparvovirus genus. It has a single promoter that generates a
50
single pre-mRNA. NP1, a small genus-specific MVC protein, participates in the processing of
51
this pre-mRNA and so controls capsid gene access via its role in alternative internal
52
polyadenylation and splicing. We show here that NP1 also controls expression of three of the
53
five identified NS proteins via its role in governing MVC pre-mRNA splicing. These NS proteins
54
are together required for virus replication in a host-cell dependent manner.
55 56
2
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
34
57
INTRODUCTION
58
Parvoviruses use multiple mechanisms to maximize the coding potential from their compact genomes, including alternative transcription initiation, alternative splicing, alternative
60
polyadenylation and alternative translation initiation mechanisms (1-3).
61
Infection with minute virus of canines (MVC), a member of the Bocaparvovirus genus (4), can
62
cause abortion and stillbirth in pregnant dogs, as well as mild gastroenteritis and respiratory
63
disease in puppies (5-8). MVC generates a single pre-mRNA from a promoter at the left-hand
64
end of the genome (P6) that is processed via alternative splicing and alternative polyadenylation
65
into multiple non-structural- and capsid-encoding transcripts (9, 10). As with other parvoviruses,
66
an open reading frame (ORF) in the left half of the genome encodes nonstructural (NS)
67
proteins, while an ORF in the right half encodes the capsid proteins VP1 and VP2 (2). The
68
bocaparvoviruses also encode a genus-specific protein, NP1, from a small ORF spanning the
69
center of the genome (9, 11). As seen for other parvoviruses, the NS proteins of MVC were
70
predicted to play multifunctional roles during infection; inspection of the MVC NS ORF identifies
71
a DNA binding/endonuclease domain within their shared amino-terminus, a helicase domain in
72
the relative center of the ORF, and a zinc-finger motif at its carboxyl-terminus. MVC NS proteins
73
have been shown to help initiate and sustain the replication of the viral genome, are required for
74
virus packaging, and mediate a number of important viral/host-cell interactions (12-18). NP1 is a
75
distinct Bocaparvovirus non-structural protein that modulates RNA processing via the
76
suppression of the internal polyadenylation signal (pA)p located in the middle of the genome. It
77
is also required for the splicing of the 3D/3A intron that lies immediately upstream of (pA)p (19).
78
Both of these processes are necessary to gain proper access to the capsid gene ORF (19, 20) .
79
We have found that that MVC generates a greater diversity of NS proteins than has
80
been previously identified; alternative splicing of RNAs from the MVC NS region led to the
81
generation of five NS proteins. Three of these proteins were generated from spliced mRNAs 3
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
59
that fused their carboxyl termini in-frame with the carboxyl terminus of NP1. The mRNAs
83
encoding these proteins utilize the 3D/3A intron and, consistent with our previous
84
characterization of the role of NP1 in splicing of this intron, we found that generation of these
85
mRNAs was dependent upon NP1. All NS isoforms share the same initiating AUG and the origin
86
binding/endonuclease domain that is conserved among Parvoviridae NS1 and Rep proteins.
87
Splice-site mutations which prevented expression of all three of the proteins derived from RNAs
88
using the 3D/3A intron inhibited virus replication in a host cell-dependent manner. Thus, in
89
addition to its role in accessing the viral capsid genes, NP1 is also necessary for efficient
90
expression of a subset of essential NS proteins, by virtue of its role in RNA processing.
91 MATERIALS AND METHODS
92 93
Cells and viruses/infections and transfections. All experiments were carried out as
94
specified in Walter Reed - 3873D (WRD) canine cells, Madin-Darby canine kidney (MDCK) cells
95
or human 293T, which were propagated as previously described (17, 21) in Dulbecco’s modified
96
Eagle medium (DMEM) with 10% or 5% fetal calf serum. The minute virus of canines (MVC)
97
used in this study was the original strain (GA3), obtained from Colin Parrish at Cornell
98
University. The infectious molecular clone pIMVC, GenBank accession number FJ214110.1,
99
used for transfection and generation of mutants was constructed by J. Qiu and described
100
previously (10). Transfections of WRD, MDCK and 293T cells were performed with either
101
Lipofectamine Plus (Life technologies, CA) or LipoD293 transfection reagent (SignaGen
102
Laboratories, MD).
103
Immunoblot analyses. Cells grown and transfected in 60mm dishes with various
104
constructs as described in the text were harvested 48hrs post-transfection, and lysed in either
105
Laemmli buffer with 2%SDS, RIPA buffer (10mM Tris pH7.5, 150mM NaCl, 1 mM EDTA,
4
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
82
1%Triton X100,0.5% Sodium Deoxycholate and 0.1%SDS) or WL lysis buffer (50mM Tris
107
pH8.0, 400mM NaCl, 1mM EDTA, 0.5%NP40, and 10% glycerol) which contained protease and
108
phosphatase inhibitors. Bradford assay of cell lysates was carried out to determine total protein
109
concentration in each lysate. SDS-PAGE and Western blotting were performed as previously
110
described (20).
111
Ribonuclease protection assays. Total RNA was isolated using the TRIzol reagent
112
(Invitrogen) and RNase protections were performed as previously described (22).The 2A\3D
113
probe (nts 2344-2550) which spanned the MVC second acceptor at nt 2386 and third donor at
114
nt 2490 was used to analyze the splicing across the MVC second and third introns.
115
Antibodies. Polyclonal antibodies directed against MVC NS epitope (NS ORF amino
116
acids 687-700; PKKQRKTEHKVLID) and MVC NP1 epitope (NP1 amino acids 1-13;
117
MSTRHMSKRSKAR) were utilized for MVC NS protein immunoblotting. Although 4 of 13 amino
118
acids of the NS protein antibody are missing in NS84 and NS50, this antibody detects NS100,
119
NS84, NS66 and NS50 at similar ratios to the proteins tagged with FLAG or HA and detected
120
with commercial anti-tag antibodies (see Figures 2B and 3B). Monoclonal antibodies against
121
FLAG, HA and tubulin epitopes (Sigma, St. Louis) were used for immunoblotting as previously
122
described (20).
123
Immunofluorescence analyses. Cells grown in 6-well plates on cover slips and
124
transfected constructs as described in the text were harvested 48hrs post-transfection, and fixed
125
in 4% paraformaldehyde in phosphate buffered saline (PBS) for 15 minutes. Cells were washed
126
twice with PBS and then permeabilized with 0.5% Triton-X in PBS for 10 minutes. Primary and
127
secondary antibodies were diluted in 3% bovine serum albumin (BSA) in phosphate buffered
128
saline (PBS). Cells were incubated with primary antibodies for 1hr followed by a wash with 3%
129
BSA in PBS. This was followed by incubation with appropriate Alexa-488 tagged secondary
130
antibodies. Nuclei were visualized with 4’, 6-diamidino-2-phenylindole (DAPI). The slips were 5
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
106
131
mounted on slides in Fluoromount-G (Southern Biotech, AL). Image analysis was carried out
132
with a Leica TCP SP8 MP confocal microscope. All images were taken with 63X objective. Southern blotting. WRD and 293T cells were transfected with the pIMVC and pIMVC-
134
derived mutant constructs as described in the text. DNA was extracted 48hrs post-transfection
135
and DNA replication was assayed by Southern blotting as described previously (17, 23) using a
136
random primed radio-labelled Not I digested genomic fragment of the pIMVC as probe. Loading
137
of samples was standardized using a Nanodrop spectrophotometer.
138
Plasmid constructs. The generation of the multiple plasmid constructs used in this
139
study are described below.
140
pIMVC (WT), pIMVC 3Am, : the wild type infectious clone (WT) (10) and the third intron
141
acceptor mutant (3Am) (20) were generated as previously described.
142
pIMVC 1Am: mutation of the splice acceptor site of MVC first intron (nt 2199) was generated as
143
an in-frame G-to-A substitution.
144
pIMVC 1AmΔ3DA: this mutant was generated by site directed mutagenesis by insertion of a
145
gene-block synthesized oligonucleotide (IDT, IA) that lacked nts 2490-3037 between the EcoRI
146
site (nt 2345) and PvuII site (nt 3060). This generated a construct with deletion of MVC third
147
intron in pIMVC1Am background.
148
pIMVC NS-66, pIMVC NS-50, and pIMVC NS-40: these constructs were generated by cloning
149
the respective cDNAs encoding each NS isoform into pIMVC WT with primers flanking the XbaI
150
(nt 868) and PvuII (nt 3060) sites.
151
3XF NS-66, 3XF NS-50 and 3XF NS-40: the cDNAs encoding NS-66, NS-50 and NS-40 were
152
cloned into the CMV 3XFLAG 7.1 expression vector (Sigma, St. Louis).
153
pIMVC NSNP1fus: a single nucleotide deletion at nt 2536 fused the NS ORF to NP1 ORF.
154
TCGGCCGAGCAATATGTC to TCGGCCGAGCAAATG
6
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
133
pIMVC NP1m: this functionally defective mutant of NP1 was generated by introducing five
156
consecutive proline substitutions into the NP1 ORF at nt 2780 [the previously described 5X-pro
157
mutant,(20) ].
158
pIMVC 3DAm was generated by debilitating the third intron splice donor at nt 2491 via an in-
159
frame G-to-A substitution in the NS ORF in combination with the third nucleotide substitutions
160
between nts 3026-3040: GTTCTCACACAGGAT to GTGCTGACACAAGAC which surround the
161
third intron acceptor (indicated in bold and underlined).
162
pIMVC 3097HA (WT, NP1m): this mutant, created both in the wild-type and NP1-mutant
163
infectious molecular clone backgrounds, was generated by site directed mutagenesis which
164
introduced an HA epitope upstream of NP1 termination codon.
165 166
RESULTS
167
MVC encodes a larger spectrum of nonstructural proteins than previously determined. In
168
previous studies we identified two proteins encoded by the left-end nonstructural gene of MVC
169
in addition to the centrally encoded NP1 protein (20). These NS proteins migrated at ~84 and
170
~66 kDa, respectively. We demonstrated that the ~66 kDa protein was encoded by a doubly-
171
spliced RNA (R3; as diagrammed in Fig. 1C). While the derivation of the ~84 kDa protein was
172
not determined, we speculated (in retrospect, incorrectly), based on predicted molecular weight,
173
that it was encoded by the uninterrupted ORF which spanned the entire NS region present
174
within the unspliced RNA that had been described (indicated as R1 in Fig 1C).
175
A more detailed examination using an antibody specific to an epitope within the
176
carboxyl-terminal region of the MVC NS ORF (nts 403-2727), indicated by the star in Fig. 1C),
177
allowed us to identify 4 proteins that utilize the NS gene region during virus infection (Fig. 1A,
178
lane 2). (A fifth NS protein will be discussed below.) In addition to the previously identified
179
abundant ~84 kDa and ~66kDa proteins, this antibody revealed NS proteins of ~100 kDa and
7
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
155
~50 kDa that appeared at lower abundance. Expression of these four proteins was also
181
detected following the transfection of the infectious clone of MVC in 293T cells (Fig. 1A, lane 4).
182
Insertion of a terminating TAA codon at nt 427 in the infectious clone of MVC confirmed that,
183
following transfection of 293T cells, all four NS proteins (but not NP1) utilize the previously
184
identified NS gene AUG at nt 403 (Fig. 1A, lane 5).
185
Three of the newly identified NS proteins are generated from RNAs which excise
186
the 3D/3A intron and join the NS ORF to the NP1 ORF. To identify the coding regions for
187
these newly identified NS proteins we first performed RT-PCR assays to identify spliced RNAs
188
from the NS region that could potentially encode these proteins. Using probes spanning nts 868
189
to 3097 (diagrammed in Fig.1C), RNA generated by the infectious clone pIMVC generated
190
distinct RT-PCR species of 1683 nts, 1224 nts, 678 nts, and 464 nts (Fig. 1B) following
191
transfection of 293T cells. These products were individually cloned into bacterial plasmids, and
192
sequencing identified these as corresponding to the RNA species R2, R3, R4, and R5,
193
respectively, as diagrammed in Fig. 1C. Of note, RNAs R2, R4 and R5 utilize the viral 3A
194
acceptor, and thus putatively fused the carboxyl-terminal region of NP1 in-frame with upstream
195
NS ORF.
196
The individual cDNAs representing the various splicing patterns were then cloned in
197
place into the full-length clone of MVC. These constructs were transfected into 293T cells and
198
extracts were analyzed by immunoblot using the same antibody to the C-terminal region of NS
199
as described above. The 1224 nt cDNA, representing the R3 transcripts (see Fig. 1B),
200
generated a single protein with a mobility of ~66k Da as expected (Fig. 2A, lane 5). Similarly,
201
the 678 nt cDNA, representing the R4 transcripts (see Fig. 1B), generated a single protein with
202
a mobility of approximately 50 kDa (Fig 2A, lane 6). As expected, expression of the 464 nt
203
cDNA, which represents the R5 transcripts, did not generate a protein detected by this antibody
204
(data not shown). This will be addressed further below. 8
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
180
205
When we expressed the largest 1683 nt cDNA, representative of the R2 transcripts, we were surprised to see the generation of a protein of ~50 kDa (data not shown). Upon further
207
examination, we found that as expressed, this RNA had been further spliced at both upstream
208
introns, yielding an R4-like transcript. In a separate set of experiments, we fortuitously found
209
that silent mutation of the 1A donor site, constructed so as to not change the NS amino acid
210
sequence, prevented all splicing of the MVC pre-mRNAs. This mutant generated only a single
211
protein with a mobility of approximately 100 kDa (Fig. 2A, lane 3). The reason that this mutant
212
did not undergo additional splicing has not yet been determined. However, the result confirmed
213
that the unspliced R1 transcripts encodes a protein of 100 kDa - rather than the largest of the
214
proteins we had identified in our previous study (i.e., the 84 kDa species) - which had been our
215
previous assumption based solely on predicted molecular weight. Cloning the 3D/3A cDNA into
216
the 1A mutant background to prevent further splicing (generating, in essence, the R2 transcript
217
diagrammed in Figure 1C), produced a single protein of 84 kDA (Fig. 2A, lane 4). These results
218
confirmed that the 100kDa, 84 kDa, 66 kdA, and 50 kDa proteins detected in Fig. 1, were
219
generated by the R1, R2, R3, and R4 classes of transcripts, respectively.
220
As mentioned, sequencing of the 464 nt cDNA indicated that it lacked the epitope used
221
for detection in the experiment shown in Fig. 1A and Fig 2A. Thus, we cloned the 464 nt cDNA -
222
and in addition the 1224 nt and 678 nt cDNAs (encoding the 66 and 50 kDa proteins,
223
respectively) as controls - into a CMV-driven expression vector containing a FLAG tag at the
224
amino terminus of the NS open reading frame. As seen previously, immunoblotting of extracts
225
generated following transfection of these constructs using the anti-NS antibody detected only
226
the 66 and 50 kDa proteins (Fig. 2B, lanes 3-5), while the anti-FLAG antibody identified the 40
227
kDa protein as the product of the 464 cDNA (Fig. 2B, lanes 6-8), which represented the R5
228
transcripts diagrammed in Figure 1C.
9
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
206
229
To confirm that the 84 kDa, 50 kDa and 40 kDa NS proteins utilize a different carboxylterminal exon than the 66kDa and 100 kDa proteins, we explored the prediction that deletion of
231
a single nucleotide which fuses the NS ORF to the NP1 ORF (within the 3D/3A intron, nt 2536),
232
would increase the size of only the 66 kDa and 100 kDa NS proteins (mutation diagrammed in
233
Fig. 2C; c.f. Fig. 1C). The results following transfection of this mutant (NSNP1fus; Fig. 2D, lane
234
3) demonstrate this to be the case. The levels of the 84 and 50 kDa proteins generated by the
235
NS/NP1 fusion shown in Fig. 2D, lane 3 are relatively low, likely because as a fusion protein, a
236
significant proportion of the NP1 present is mutant and poorly functional. NP1 is required for
237
splicing of the 3A/3D intron (19) and the potential role for NP1 in this observation can be
238
explained as discussed below.
239
NP1 governs expression of three NS proteins via its role in splicing the 3D/3A
240
intron. Since NP1 is required for splicing of the 3A/3D intron (19), it seemed likely that NP1 may
241
govern expression of the 84 kDa, 50 kDA, and 44 kDa NS proteins. To investigate this
242
possibility, we analyzed expression following transfection of 293T cells of the wild-type and
243
NP1-mutant MVC infectious clones bearing an HA epitope inserted at nt 3097 at the carboxyl
244
termini of the NP1 ORF (triangle in Fig. 1C). For these experiments we assayed both RNA
245
production using RNase protection assays, and protein production using antibodies directed
246
either to HA or to the previously described epitope at the carboxyl-terminus of the NS ORF (star
247
in Fig. 1C). The HA insertion itself had only a slight effect on splicing of the 3D/3A intron in the
248
presence of otherwise wild-type NP1 (Fig. 3A, compare lane 5 to lane 2). Mutation of NP1 [the
249
previously described mutant bearing an insertion of 5 proline residues which abrogated NP1’s
250
roles in 3D/3A splicing and suppression of (pA)p (19) ], led to a decrease in splicing of the
251
3D/3A intron, both in the wild-type as expected, and to a slightly lesser extent, in the HA-tagged
252
construct (Fig. 3A, compare lane 6 to lane 3). As can be seen in Fig. 3B, corresponding to the
253
decrease in splicing of the 3A/3D intron seen in the NP1-mutant constructs, the levels of
10
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
230
expression of the 84 kDa, and 50 kDa proteins were significantly reduced (the 40 kDa protein
255
was poorly expressed in this experiment), as detected by the anti-HA antibody at the carboxyl
256
termini of the NP1 exon (Fig. 3B, compare lane 3 to 2). Reduced expression of the 84 kDa and
257
50 kDa proteins was also seen in the NP1-mutant transfection when detected by the antibody to
258
the carboxyl-terminus of NS (which does not detect the 40 kDa protein; Fig. 3B, compare lanes
259
6 to 5). These results demonstrate that NP1, which is required for the excision of the 3D/3A
260
intron, governs the expression of the 84 kDa, 50 kDa (and we expect also the 40 kDa) proteins
261
which are derived from mRNAs from which the 3D/3A intron is excised.
262
The individual NS proteins exhibit a complex localization pattern. Generation of
263
vectors that individually expressed the various NS isoforms allowed a general determination of
264
their localization, and perhaps provide insights into their potential function during the viral life
265
cycle. At 48 hrs following transient transfection of replication competent pIMVC in WRD cells,
266
immunostaining, using the anti-NS antibody whose epitope is designated by the star in Fig. 1C,
267
demonstrated that when expressed together, the 100 kDa, 84 kDa, 66 kDa, and 50 kDa proteins
268
exhibited a diffuse distribution in the nucleoplasm (Fig. 4A panel 1). Replication-defective
269
pIMVC 1Am and pIMVC 1AmΔ3DA constructs which individually encode R1 and R2 transcripts,
270
that are translated into NS-100 and NS-84, respectively, exhibited both nuclear and cytoplasmic
271
NS localization. The isoforms have a partial-to-complete diffuse nucleoplasmic distribution with
272
multiple cytoplasmic aggregates (Fig. 4A, panels 2 and 3). NS-100 seemed to form more round
273
cytoplasmic aggregates while the NS-84 isoforms generated more of interlacing filamentous
274
aggregates in the nucleus and cytoplasm. WRD cells transiently expressing NS-66 alone
275
displayed a strong diffuse nucleoplasm distribution of NS (Fig. 4A, panel 4), while cells
276
expressing NS-50 has diffuse faint nuclear distribution, apparently excluding nucleoli and
277
multiple concentrated, discreet, punctate spherical bodies within the nucleoplasm (Fig. 4A,
278
panel 5). These results indicated that while NS-100, NS-84, NS-66 and NS-50 isoforms were
11
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
254
primarily nuclear when generated together from the complete pIMVC WT clone, when
280
generated individually, their distribution and localization were quite different. Whether these
281
differences are due to differential post-translational modifications of these proteins, or
282
interactions between the proteins themselves are currently being investigated.
283
As mentioned previously, the NS antibody utilized in the experiments just described
284
does not recognize NS-40. Thus, to determine the localization of individually expressed NS-40
285
we compared the localization of N-terminal FLAG-tagged NS-66 and NS-40 following
286
immunostaining (Fig. 4B) using the anti-FLAG antibody (also used for the experiment shown in
287
Fig. 2B). FLAG-tagged NS-66 was again seen to be diffusely nuclear (Fig. 4B, panel 2),
288
consistent with our observation shown in Fig. 4A panel 4; however, NS-40 was predominantly
289
cytoplasmic (Fig. 4B, panel 1). There is a potential bipartite nuclear localization signal
290
(PSRKRTSSDETINSPPKKQRK, nts 2414-2478) that is located in the carboxyl end of the NS-
291
100, NS-84, NS-66 and NS-50 ORFs but absent in NS-40. Thus, the lack of the bipartite nuclear
292
localization signal in NS-40 may account for its predominant cytoplasmic localization.
293
The NS proteins whose expression was governed by NP1 were required for MVC
294
replication in canine but not human 293T cells. Previous results have shown that mutations
295
that prevent the production of all the MVC NS proteins prevents virus replication following
296
transfection in both canine and 293T cells, and that neither the MVC 100 kDa nor 66 kDa NS
297
protein can sustain MVC replication alone (10, 20). Additional experiments have shown that, as
298
seen for certain other parvoviruses, mutations that prevent MVC VP1 and VP2 production still
299
allow wild-type levels of mRF production ((20); Fasina and Pintel, unpublished). To determine
300
the importance in replication of the NP1-ORF containing NS-84, NS-50 and NS-40 proteins, we
301
inserted into the MVC infectious clone a mutation which debilitated both the donor and acceptor
302
of the 3D/3A intron without changing the NS-100 and NS-66 amino-acid sequence (3DAm,
303
diagrammed in Fig. 5A). This mutation would also be expected to prevent capsid protein 12
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
279
production which requires mRNAs spliced using the A3 acceptor. As expected, this mutant
305
generated the NS-100 and NS-66 proteins, but not NS-84, NS-50 (Fig. 5B) or NS-40 (data not
306
shown) following transfection of 293T cells. A similar expression profile was seen in WRD cells,
307
which transfect poorly (data not shown). Following transfection, the pIMVC 3D/3A mutant
308
(3DAm) failed to replicate in both canine cells tested: WRD (Fig. 5C, compare lanes 3 and 6 to
309
lanes 2 and 5) or MDCK (Fig. 5D, compare lanes 3 and 6 to 2 and 5). In contrast, however, the
310
3DAm mutant replicated to similar levels as wild type pIMVC following transfection of 293T cells
311
(Fig. 5E compare lanes 4 and 6 to lanes 3 and 5 – 293T cells are not susceptible to direct MVC
312
viral (re)infection). These results indicated that while the NS-84, NS-50 and NS-40 proteins
313
were essential for replication of MVC in canine cells, these proteins were dispensable for
314
replication in 293T cells.
315 316 317
DISCUSSION In this manuscript we expand the identification of MCV NS proteins to five, and show
318
that three newly identified MVC NS proteins (84 kDa, 50 kDa and 40 kDa) are generated from
319
mRNAs spliced at the 3D/3A intron. In each case splicing of 3D/3A fuses the 3’ ends of the NS
320
proteins to the NP1 ORF. NP1, which is required for efficient splicing of the 3D/3A intron,
321
governs expression of these NS proteins by virtue of its enhancement of 3D/3A excision. Thus,
322
in addition to controlling capsid gene access via its role in alternative polyadenylation of the
323
internal polyadenylation site (pA)p (20), and splicing of the 3D/3A intron (19), NP1 also controls
324
expression of three of the five identified NS proteins via its role in splicing. Mutations which
325
prevent expression of these three proteins inhibit virus replication in a host dependent manner.
326
It is not yet fully clear if there is a difference in NS protein expression from RNAs that utilize
327
(pA)p or read-through to the distal polyadenylation site (pA)d.
13
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
304
328
Similarities between the 84 kDa, 50 kDa, and 40 kDa MVC NS proteins and the NS2 proteins of minute virus of mice (MVM) bear mentioning. Similar to the case for MVC, splicing of
330
the RNA generating MVM NS2 joins the amino terminal MVM NS1 ORF into a separate ORF at
331
the carboxyl end of the NS gene (24-27). Additionally, as is the case for the minor MVC NS
332
proteins, MVM NS2 has been shown to be required for replication of MVM in a host-dependent
333
manner. While restricted in murine host cells, MVM NS2 mutants replicate in a wide variety of
334
transformed cells from various species (28-31), and perhaps analogously, the MVC mutants that
335
do not produce the 3D/3A spliced NS proteins are restricted for growth in canine cells yet
336
replicate efficiently in human 293T cells. The extent to which host-range replication for these
337
mutants extends is currently being investigated. Additionally, the Tattersall lab has pointed out
338
that MVM NS2 and the human bocavirus HBoV NP1 both bear Crm1 binding and 14-3-3 binding
339
sites, and HBoV NP1 can complement certain early functions of MVM NS2 (32). Together,
340
these results suggest an intriguing similarity in the small NS proteins of parvoviruses.
341
Surprisingly, the MVC NS proteins migrate surprisingly differently on SDS-PAGE gels
342
than expected based on their molecular weight as predicted from their amino acid composition
343
(Fig. 1C). This led us previously to assume that the protein migrating at approximately 84 kDa
344
was generated from the uninterrupted NS ORF (c.f. Fig 1C). This also initially confounded our
345
mapping of the various MVC NS proteins until cDNAs of each were generated. Why the
346
migration of these proteins is so different than their predicted molecular weight is not yet clear.
347
The unexpected migrations observed may certainly be due to post-translational modifications;
348
the NS proteins generated by other parvovirus genera have been shown to be highly modified
349
by phosphorylation and acetylation (33-37).
350
The conserved N-terminal region of the MVC NS proteins encodes a histidine-
351
hydrophobic-histidine (HUH) endonuclease motif (38, 39), also conserved in other parvoviral
352
nonstructural proteins (13, 39), which is required for site-specific DNA cleavage and ligation 14
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
329
during rolling-hairpin replication (12, 40). The active site of the MVC HUH motif would be
354
predicted to be H122, L123 and H124 which are present in all the MVC NS isoforms (Fig. 4B).,
355
suggesting that all MVC NS isoforms may interact with the viral genome. As in other viral HUH
356
motif-containing proteins (12, 14, 38, 41) there is an SF3 helicase domain with characteristic
357
Walker A (FYGPASTGKTN aa 423-433), B (LICWWEEC aa 464-471) C (KCIMGGTQFRIDRK
358
aa 482-495) and C’ (PQTPLIISTNHNI aa 503-515) motifs (42) downstream of the HUH motif in
359
NS-100 and NS-84 proteins (amino acids 1-696 are identical in NS-100 and NS-84 ); however,
360
it is removed by alternative splicing and absent in the NS-66, NS-50 and NS-40 proteins,
361
suggesting distinct differences in function. And although NS-100 and NS-84 proteins contain
362
HUH endonuclease and SF3 helicase domains, they have distinct carboxyl terminal ends which
363
likely contribute to important differences. Furthermore, NS-84, NS-50 and NS-40 share a
364
conserved 19 amino-acid carboxyl terminal domain with NP1.
365
In-silico analysis also suggests a strong bipartite nuclear localization signal
366
(PSRKRTSSDETINSPPKKQRK – nts 2414-2478) that is located in the carboxyl end of all the
367
NS isoforms except the NS-40 protein. We find that the FLAG-tagged NS-66 displays a
368
diffusely nuclear localization, while the NS-40 protein is predominantly cytoplasmic, perhaps
369
suggesting that the lack of the bipartite nuclear localization signal may alter its cellular
370
localization.
371
It has recently been shown that interactions between intrinsically disordered domains of
372
viral and host proteins can modulate certain host cellular responses to virus infection, such as
373
the DNA damage response (43). In-silico analysis shows that MVC NS-84, NS-50 and NS-40
374
share a highly disordered domain in their carboxyl termini with NP1 (data not shown). It is
375
conceivable that these regions may play important roles in their function. Although the 3D/3A
376
mutant replicates well in 293T cells, virus is not produced because capsid protein production is
377
prevented. Mutants are currently being constructed which prevent the production of NS-84, NS15
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
353
378
50, and NS-40, yet allow capsid protein production. These mutations should aid further analysis
379
of the role of these NS proteins during virus infection.
381
expressed (44-51). The Bocaparvoviruses, which have a single promoter, make extensive use
382
of RNA processing to properly express their genetic information, and encode a genus-specific
383
protein, NP1, that participates in this processing (19, 20). In addition to enhancing access to the
384
capsid coding gene, MVC NP1, by virtue of its role in splicing, also controls expression of three
385
NS proteins that play important roles in virus replication. Thus MVC NP1 influences viral RNA
386
processing for expression of both its non-structural and structural genes, adding to the variety of
387
strategies utilized by parvoviruses to maximize their genome coding potentials.
388 ACKNOWLEDGEMENTS
389 390
We thank Lisa Burger for excellent technical assistance, and members of the lab for advice and discussion. We thank Jianming Qiu for information prior to publication.
391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409
REFERENCES 1. 2. 3. 4. 5. 6. 7.
Qiu J, Pintel D. 2008. Processing of adeno-associated virus RNA. Front Biosci 13:31013115. Cotmore SF, Tattersall P. 2014. Parvoviruses: Small Does Not Mean Simple. Annual Review of Virology 1:517-537. Kailasan S, Agbandje-McKenna M, Parrish CR. 2015. Parvovirus Family Conundrum: What Makes a Killer? Annu Rev Virol 2:425-450. Cotmore S, Agbandje-McKenna M, Chiorini J, Mukha D, Pintel D, Qiu J, SoderlundVenermo M, Tattersall P, Tijssen P, Gatherer D, Davison A. 2014. The family Parvoviridae. Archives of Virology 159:1239-1247. Decaro N, Carmichael LE, Buonavoglia C. 2012. Viral reproductive pathogens of dogs and cats. Vet Clin North Am Small Anim Pract 42:583-598, vii. Harrison LR, Styer EL, Pursell AR, Carmichael LE, Nietfeld JC. 1992. Fatal disease in nursing puppies associated with minute virus of canines. J Vet Diagn Invest 4:19-22. Carmichael LE, Schlafer DH, Hashimoto A. 1991. Pathogenicity of minute virus of canines (MVC) for the canine fetus. Cornell Vet 81:151-171.
16
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
Parvoviruses exhibit a surprisingly wide variability in how their genomes are
380
8. 9. 10. 11. 12. 13. 14.
15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26.
Macartney L, Parrish CR, Binn LN, Carmichael LE. 1988. Characterization of minute virus of canines (MVC) and its pathogenicity for pups. Cornell Vet 78:131-145. Schwartz D, Green B, Carmichael LE, Parrish CR. 2002. The canine minute virus (minute virus of canines) is a distinct parvovirus that is most similar to bovine parvovirus. Virology 302:219-223. Sun Y, Chen AY, Cheng F, Guan W, Johnson FB, Qiu J. 2009. Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J Virol 83:3956-3967. Lederman M, Patton JT, Stout ER, Bates RC. 1984. Virally coded noncapsid protein associated with bovine parvovirus infection. J Virol 49:315-318. Hickman AB, Ronning DR, Kotin RM, Dyda F. 2002. Structural unity among viral origin binding proteins: crystal structure of the nuclease domain of adeno-associated virus Rep. Mol Cell 10:327-337. Hickman AB, Ronning DR, Perez ZN, Kotin RM, Dyda F. 2004. The nuclease domain of adeno-associated virus rep coordinates replication initiation using two distinct DNA recognition interfaces. Mol Cell 13:403-414. Yoon-Robarts M, Blouin AG, Bleker S, Kleinschmidt JA, Aggarwal AK, Escalante CR, Linden RM. 2004. Residues within the B' motif are critical for DNA binding by the superfamily 3 helicase Rep40 of adeno-associated virus type 2. J Biol Chem 279:5047250481. Bardelli M, Zarate-Perez F, Agundez L, Linden RM, Escalante CR, Henckaerts E. 2016. Identification of a Functionally Relevant Adeno-Associated Virus Rep68 Oligomeric Interface. J Virol 90:6612-6624. Tewary SK, Liang L, Lin Z, Lynn A, Cotmore SF, Tattersall P, Zhao H, Tang L. 2015. Structures of minute virus of mice replication initiator protein N-terminal domain: Insights into DNA nicking and origin binding. Virology 476:61-71. Fasina O, Pintel DJ. 2013. The adeno-associated virus type 5 small rep proteins expressed via internal translation initiation are functional. J Virol 87:296-303. King JA, Dubielzig R, Grimm D, Kleinschmidt JA. 2001. DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J 20:3282-3291. Fasina OO, Dong Y, Pintel DJ. 2015. NP1 Protein of the Bocaparvovirus Minute Virus of Canines Controls Access to the Viral Capsid Genes via Its Role in RNA Processing. J Virol 90:1718-1728. Sukhu L, Fasina O, Burger L, Rai A, Qiu J, Pintel DJ. 2013. Characterization of the nonstructural proteins of the bocavirus minute virus of canines. J Virol 87:1098-1104. Binn LN, Lazar EC, Eddy GA, Kajima M. 1970. Recovery and characterization of a minute virus of canines. Infect Immun 1:503-508. Venkatesh LK, Fasina O, Pintel DJ. 2012. RNAse mapping and quantitation of RNA isoforms. Methods Mol Biol 883:121-129. Farris KD, Fasina O, Sukhu L, Li L, Pintel DJ. 2010. Adeno-associated virus small rep proteins are modified with at least two types of polyubiquitination. J Virol 84:1206-1211. Pintel D, Dadachanji D, Astell CR, Ward DC. 1983. The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units. Nucleic Acids Res 11:1019-1038. Cotmore SF, Sturzenbecker LJ, Tattersall P. 1983. The autonomous parvovirus MVM encodes two nonstructural proteins in addition to its capsid polypeptides. Virology 129:333-343. Jongeneel CV, Sahli R, McMaster GK, Hirt B. 1986. A precise map of splice junctions in the mRNAs of minute virus of mice, an autonomous parvovirus. J Virol 59:564-573. 17
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459
27. 28. 29. 30. 31.
32. 33. 34. 35. 36. 37.
38. 39. 40. 41. 42.
Qiu J, Yoto Y, Tullis G, Pintel DJ. 2006. RNA processing strategies pp 253-270, Parvoviruses. Edited by Jonathan Kerr, Susan Cotmore, Marshall Bloom, Michael Linden and Colin Parrish, 1st ed. Hodder Arnold London, Great Britain. Naeger LK, Cater J, Pintel DJ. 1990. The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious virus production in a cell-type-specific manner. J Virol 64:6166-6175. Naeger LK, Salome N, Pintel DJ. 1993. NS2 is required for efficient translation of viral mRNA in minute virus of mice-infected murine cells. J Virol 67:1034-1043. Ruiz Z, D'Abramo A, Jr., Tattersall P. 2006. Differential roles for the C-terminal hexapeptide domains of NS2 splice variants during MVM infection of murine cells. Virology 349:382-395. Brownstein DG, Smith AL, Johnson EA, Pintel DJ, Naeger LK, Tattersall P. 1992. The pathogenesis of infection with minute virus of mice depends on expression of the small nonstructural protein NS2 and on the genotype of the allotropic determinants VP1 and VP2. J Virol 66:3118-3124. Mihaylov IS, Cotmore SF, Tattersall P. 2014. Complementation for an essential ancillary non-structural protein function across parvovirus genera. Virology 468-470:226237. Nuesch JP, Corbau R, Tattersall P, Rommelaere J. 1998. Biochemical activities of minute virus of mice nonstructural protein NS1 are modulated In vitro by the phosphorylation state of the polypeptide. J Virol 72:8002-8012. Nuesch JP, Dettwiler S, Corbau R, Rommelaere J. 1998. Replicative functions of minute virus of mice NS1 protein are regulated in vitro by phosphorylation through protein kinase C. J Virol 72:9966-9977. Corbau R, Duverger V, Rommelaere J, Nuesch JP. 2000. Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 278:151-167. Nuesch JP, Christensen J, Rommelaere J. 2001. Initiation of minute virus of mice DNA replication is regulated at the level of origin unwinding by atypical protein kinase C phosphorylation of NS1. J Virol 75:5730-5739. Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schnolzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A. 2013. Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. EMBO Mol Med 5:15371555. Chandler M, de la Cruz F, Dyda F, Hickman AB, Moncalian G, Ton-Hoang B. 2013. Breaking and joining single-stranded DNA: the HUH endonuclease superfamily. Nat Rev Microbiol 11:525-538. Tewary SK, Zhao H, Shen W, Qiu J, Tang L. 2013. Structure of the NS1 protein Nterminal origin recognition/nickase domain from the emerging human bocavirus. J Virol 87:11487-11493. Musayev FN, Zarate-Perez F, Bishop C, Burgner JW, 2nd, Escalante CR. 2015. Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1. J Biol Chem 290:27487-27499. James JA, Aggarwal AK, Linden RM, Escalante CR. 2004. Structure of adenoassociated virus type 2 Rep40-ADP complex: insight into nucleotide recognition and catalysis by superfamily 3 helicases. Proc Natl Acad Sci U S A 101:12455-12460. Hickman AB, Dyda F. 2005. Binding and unwinding: SF3 viral helicases. Curr Opin Struct Biol 15:77-85.
18
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509
43.
44. 45. 46.
47. 48. 49. 50. 51.
Lou DI, Kim ET, Meyerson NR, Pancholi NJ, Mohni KN, Enard D, Petrov DA, Weller SK, Weitzman MD, Sawyer SL. 2016. An Intrinsically Disordered Region of the DNA Repair Protein Nbs1 Is a Species-Specific Barrier to Herpes Simplex Virus 1 in Primates. Cell Host Microbe 20:178-188. Schoborg RV, Pintel DJ. 1991. Accumulation of MVM gene products is differentially regulated by transcription initiation, RNA processing and protein stability. Virology 181:22-34. Qiu J, Pintel DJ. 2002. The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template. Mol Cell Biol 22:3639-3652. Qiu J, Nayak R, Pintel DJ. 2004. Alternative polyadenylation of adeno-associated virus type 5 RNA within an internal intron is governed by both a downstream element within the intron 3' splice acceptor and an element upstream of the P41 initiation site. J Virol 78:83-93. Zhao Q, Schoborg RV, Pintel DJ. 1994. Alternative splicing of pre-mRNAs encoding the nonstructural proteins of minute virus of mice is facilitated by sequences within the downstream intron. J Virol 68:2849-2859. Li L, Qiu J, Pintel DJ. 2009. The choice of translation initiation site of the rep proteins from goose parvovirus P9-generated mRNA is governed by splicing and the nature of the excised intron. J Virol 83:10264-10268. Liu Z, Qiu J, Cheng F, Chu Y, Yoto Y, O'Sullivan MG, Brown KE, Pintel DJ. 2004. Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. J Virol 78:12929-12939. Qiu J, Cheng F, Pintel D. 2007. Distance-dependent processing of adeno-associated virus type 5 RNA is controlled by 5' exon definition. J Virol 81:7974-7984. Qiu J, Cheng F, Yoto Y, Zadori Z, Pintel D. 2005. The expression strategy of goose parvovirus exhibits features of both the Dependovirus and Parvovirus genera. J Virol 79:11035-11044.
537
538
Figure 1. MVC encodes multiple NS isoforms during infection of WRD cells and
539
transfection of 293T cells. (A) (Left panel) Immunoblots, using antibodies directed against the
540
NS ORF (epitope depicted as a star) or NP1 (epitope depicted as a circle), of cell lysates of
541
either mock infected, (M, lane 1), or WRD cells infected with MVC at a moi of 7 harvested 48hrs
542
post-infection (lane 2). (Right panel) Immunoblots, using antibodies directed against the NS
543
ORF (star), NP1 (circle), or tubulin, of 293T cell lysates harvested 48 hrs post-transfection with
544
either pIMVC WT (lane 4), pIMVC 427 TAA (terminating the NS ORF as described, lane 5), or
545
mock-transfected (lane 3). The bands correlating to NS isoforms (NS-100, NS-84, NS-66 and
546
NS-50), and NP1 are indicated on the right, and molecular weight (MW) markers in kilodaltons
547
(kDa) are depicted on the left. (B) Reverse-transcriptase PCR of total 293T cell RNA extracted
19
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536
48hrs post-transfection with pIMVC WT, primed with oligo-deoxythymidine (Oligo-dT) and
549
reverse transcribed with (lanes 1-3, each lane represents an individual complete experiment),
550
and without (lane 4) reverse transcriptase (RT). Amplicons (1683bp, 1224bp, 678bp, and
551
464bp) generated with MVC NS ORF-specific forward (nt 868) and NP1 ORF-specific reverse
552
(nt 3097) primers, depicted with horizontal arrows in the transcription profile schematic in panel
553
C, are shown on the right side of the panel. The size markers (M), in kilobases (Kb), are
554
depicted on the left. (C) The transcription profile of MVC showing the alternative RNA
555
processing events that generate MVC nonstructural protein (NS isoforms and NP1)-encoding
556
transcripts (R1-R6) and structural protein (VP1 and VP2)-encoding transcripts (R7 and R8). The
557
NS and NP1-encoding transcripts are illustrated as alternatively polyadenylated transcripts
558
using the proximal (pA)p (R1-R6s), or distal (pA)d (R1-R6l) polyadenylation sites. The P6
559
promoter, splice donors (D) and acceptors (A), and the proximal (pA)p and distal (pA)d
560
polyadenylation sites are shown, along with relevant nucleotide landmarks within the MVC
561
genome (GenBank accession number FJ2141101.1). The position of the NS1 termination
562
mutant (pIMVC 427 TAA) is shown with an “X”, while the position of the 5’ (nt 868) and 3’ (nt
563
3097) primers used to the RT-PCR analysis in panel B are depicted with the horizontal arrows.
564
The NS ORF (nt 403-2727) and NP1 ORF (nt 2537-3097) are indicated. The epitopes detected
565
by the antibodies used to detect the NS proteins (NS ORF amino acids 687-700:
566
PKKQRKTEHKVLID) and NP1 (NP1 amino acids 1-13: MSTRHMSKRSKARSR), are indicated
567
by the star and closed circle, respectively. The triangle indicates hemagglutinin (HA) epitope at
568
NP1 ORF carboxyl termini in pIMVC 3097HA WT and pIMVC 3097HA NP1m constructs used
569
for the experiments in Fig. 3. The predicted (pred. MW) and observed (obs. MW) molecular
570
weights of the NS isoforms (NS-100, NS-84, NS-50 and NS-40), NP1 proteins, and capsid
571
proteins (VP1 and VP2) are indicated with the corresponding number of amino acid residues
572
(774aa, 715aa, 439aa, 382aa, 309aa,186aa, 703aa and 571aa) encoded by their mRNAs.
20
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
548
573 574
Figure 2. MVC NS-84, NS-50 and NS-40 mRNAs are alternatively spliced using the 3A acceptor into the NP1 ORF. (A) Lysates of 293T cells taken 48 hrs following transfection of
576
pIMVC WT (lane 2), pIMVC 1Am (lane 3), R2 cDNA (lane 4), R3 cDNA (lane 5), R4 cDNA (lane
577
6) and R5 cDNA (lane 7) were analyzed by immunoblotting with antibodies directed against NS
578
(depicted as the star in Fig. 1C) and tubulin. Molecular weight markers (MW) are indicated on
579
the left. (B) Lysates of 293T cells taken 48 hours following transfection with pIMVC WT (lane 2)
580
or CMV-3XF constructs expressing R3 cDNA (lanes 3 and 6), R4 cDNA (lanes 4 and 7) and R5
581
cDNA (lanes 5 and 8) isoforms, were analyzed by immunoblot using either anti-NS antibody
582
(epitope depicted by star in Fig. 1C (lanes 1-5), or anti-FLAG (lanes 6-8). The size markers are
583
shown as described above. (C) Schematic of wild-type MVC nts 2524 to 2574 and pIMVC
584
NSNP1fus mutant. The “T” nucleotide (nt 2536) deleted in NS1 ORF to generate the NSNP1fus
585
mutant fusing the NS and NP1 ORFs is italicized and bolded. Reading frames are indicated by
586
lines above and below the sequences. (D) Lysates of 293T cells taken 48hrs post-transfection
587
with pIMVC WT (lane 2) and pIMVC NS1NP1fus mutant (lane 3), were immunoblotted using
588
antibodies to the NS ORF (depicted by the star in Fig. 1C). Size markers and the bands
589
correlating to each NS1 isoforms are indicated on the left and right side of the panel,
590
respectively.
591
Figure 3. MVC NP1 is required for the expression of NS-84, NS-50 and NS-40. (A)
592
RNAse protection of 20 µg of RNA extracted from 293T cells 48 hrs following transfection with
593
pIMVC WT (lane 2), pIMVC NP1m (lane 3), pIMVC 3097HA WT (lane 5), and pIMVC NP1m
594
3097HA (lane 6), using the 2A\3D probe that spans nts 2344-2550 (shown in Fig. 1C). The size
595
of the probe (243nt) and protected RNAs (206nt, 164nt and 105nt) are shown on the left. Bands
596
reflecting RNA species unspliced through this region (RT), spliced at the second intron acceptor
597
but not at the third intron donor (2Aspl/3DUnspl), and RNAs spliced at the second intron 21
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
575
acceptor and also the third intron donor (2Aspl/3Dspl), are indicated on the right. (B) Sample
599
taken from 293T cells transfected with pIMVC 3097HA WT (lanes 2 and 4), and pIMVC NP1m
600
3097HA (lanes 3 and 6) were subjected to immunoblot analysis using antibody directed against
601
HA (lanes 1-3), or antibody directed against NS (epitope depicted as a star in Fig. 1C, lanes 4-
602
6). Tubulin was monitored as a loading control. The bands that correspond to each NS isoform
603
are indicated on the right and the molecular weight (MW) size markers are shown on the left.
604
Figure 4. MVC NS isoforms exhibit differential localization and distinct
605
morphology in transiently transfected WRD cells. (A) WRD cells were transfected with
606
pIMVC WT, or pIMVC constructs expressing cDNAs individually encoding each NS1 isoform
607
(pIMVC 1Am-NS-100, pIMVC R2 1AmΔ3DA-NS-84, pIMVC R3-NS-66, and pIMVC R4- NS-50)
608
as indicated to the left, and stained 48 hrs later with anti-NS antibody (epitope depicted as a star
609
in Fig. 1C). Nuclei were visualized with DAPI staining. Representative images are shown. (B)
610
Immunofluorescence of WRD cells 48 hrs post-transfection with CMV-3XF pIMVC R5 encoding
611
NS-40 isoform and CMV-3XF pIMVC R3 encoding the NS-66 isoform, using anti- FLAG
612
antibodies. Nuclei were counter-stained with DAPI. Representative images are shown.
613
Figure 5. MVC NS-84, NS-50 and NS-40 are required for viral genome replication in
614
a host-cell dependent manner. (A) Schematic representation of MVC transcription profile as
615
described in Fig.1C. Locations of the third intron donor (3D) and acceptor (3A) mutations in
616
pIMVC 3DAm are designated by an “X” which are also underlined for clarity. (B) Lysates taken
617
from the 293T cells 48 hr following transfection with pIMVC WT (lane 2) and pIMVC 3DAm (lane
618
3) were subjected to immunobloting using antibodies directed against NS (epitope designated
619
by the star in Fig. 1C) and tubulin. The MVC NS isoforms are shown on the right and the
620
molecular weight markers are shown on the left. (C & D) Southern Blots of total DNA extracts
621
from canine WRD (C) or MDCK (D) cells taken 72 hrs post-transfection with pIMVC WT (lane 2
622
and 5), pIMVC 3DAm (lane 3 and 6), or infected with MVC virus (VI) at moi of 7 (lanes 1 and 4) 22
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
598
transferred from 1% agarose gels. DNA shown in lanes 4-6 were treated with Dpn I to
624
differentiate transfected input plasmid from monomer (mRF) and dimer (dRF) replicative
625
intermediates, designated on the left side of the panel. (E) Southern Blots of total DNA extracts
626
from human 293T cells taken 48 hr post transfection of pIMVC WT (lanes 3 and 5) or pIMVC
627
3DAm (lanes 4 and 6). Lysates from MVC infected WRD cells (lane 1) and untransfected 293T
628
cells (lanes 2 and &) were included as controls. Parallel DNA samples were treated with Dpn I
629
(lanes 5-7) to differentiate transfected input plasmid from monomer (mRF) and dimer (dRF)
630
replicative intermediates shown on the left side of the panel.
23
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
623
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND
Downloaded from http://jvi.asm.org/ on April 21, 2017 by UNIVERSITY OF NEW ENGLAND